Antidiabetic activity evaluation of glimepiride and nerium oleander extract on insulin, glucose levels and some liver enzymes activities in experimental diabetic rat model

Pakistan Journal of Biological Sciences

Volumn 14, Issue 21, 2011, Pages 984-990

  Mwafy, Saleh N ^a   Yassin, Maged M ^b  

^a AL AZHAR UNIVERSITY   (Palestine)

^b ISLAMIC UNIVERSITY OF GAZA   (Palestine)

Author keywords

Diabetic rats; Glimepiride; Nerium oleander; Streptozotocin; Therapy

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ANTIDIABETIC AGENT; ASPARTATE AMINOTRANSFERASE; GLIMEPIRIDE; INSULIN; PLANT EXTRACT; SULFONYLUREA DERIVATIVE;

ANIMAL; ARTICLE; BLOOD; CHEMICALLY INDUCED DISORDER; CHEMISTRY; DRUG EFFECT; ENZYMOLOGY; EXPERIMENTAL DIABETES MELLITUS; GLUCOSE BLOOD LEVEL; LIVER; MALE; METABOLISM; NERIUM; RAT; SPRAGUE DAWLEY RAT;

ALANINE TRANSAMINASE; ALKALINE PHOSPHATASE; ANIMALS; ASPARTATE AMINOTRANSFERASES; BLOOD GLUCOSE; DIABETES MELLITUS, EXPERIMENTAL; HYPOGLYCEMIC AGENTS; INSULIN; LIVER; MALE; NERIUM; PLANT EXTRACTS; RATS; RATS, SPRAGUE-DAWLEY; SULFONYLUREA COMPOUNDS;

EID: 82855178984     PISSN: 10288880     EISSN: 18125735     Source Type: Journal    
DOI: 10.3923/pjbs.2011.984.990     Document Type: Article

References (41)

1. ACS, 2002. American Cancer Society's Complementary and Alternative Cancer Methods Handbook. American Cancer Society, USA., Pages: 278.
2. Abu-Amra, E., 2000. Physiological studies on diabetic male albino mice treated with a Bradyhinin Potentiating Factors (BPF) separated from jelly fish and cobra anake venoms. J. Egypt. Ger. Soc. Zool., 15: 211-233.
3. Adam, S.E.I., M.A. Al-Yahya and A.H. Al-Farhan, 2001. Acute toxicity of various oral doses of dried nerium oleander leaves in sheep. Am. J. Chin. Med., 29: 525-532.
4. Alberti, K.G.M.M., P. Zimmet and R.A. DeFronzo, 1997. International Textbook of Diabetes Mellitus. 2nd Edn., John Wiley and Sons, New York, USA., ISBN: 0471939307, Pages: 1827.
5. Ali, L., A.K. Azad-Khan, Z. Hassan, M. Mosihuzzaman and N. Nahar et al., 1995. Characterization of the hypoglycemic effects of Trigonella foenum graecum seed. Planta Med., 61: 358-360.
6. Ashcroft, S.J.H. and F.M. Ashcroft, 1992. The sulfonylurea receptor. Biochem. Biophys. Acta, 1175: 45-59.
7. Ashour, A.A., M.M. Yassin and N.R. Elyazji, 2004. Improvement of glucose level, lipid profile, some enzyme activities and structure of pancreas and liver in diabetic rats treated with glibenclamide. J. Islam Univ. Gaza, 12: 139-156.
8. Bando, K. and Y. Yamada, 2001. Glimepiride (Amaryl). A review of its pharmacological and clinical profile. Nippon Yakurigaku Zasshi, 18: 59-67.
9. Baquer, N.Z., 1998. Glucose over utilization and under utilization in diabetes and effects of antidiabetic compounds. Ann. Real Farm, 64: 147-180
10. Bessey, O.A., O.H. Lowry and M.J. Brock, 1946. A method for determination of alkaline phosphatase with five cubic milliliters of serum. J. Biol. Chem., 164: 321-329.
11. Bogardus, C., S. Lillioja, V. Howard, G. Reaven and D. Mott, 1984. Relationships between insulin secretion, insulin action and fasting plasma glucose concentration in nondiabetic and noninsulin-dependant diabetic subjects. J. Clin. Invest., 74: 1238-1246.
12. Cheta, D.M., J. Lim, E.K. Chan, T. Kunakorn and M.A. Charles, 1995. Glimepiride-induced prevention of diabetes and autoimmune events in the BB rat: Revised. Life Sci., 57: 2281-2290.
13. Defranzo, R.A. and D.C. Simonson, 1992. Glucose Toxicity. In: Advances in Endocrinology and Metabolism, Kreisberg, R.A. (Ed.). Mosby, Louis, Missouri, United States, pp: 1-53.
14. El-Agouza, I., A. Rawy, A. Saad, A. Lashin and S. El-Sisi, 2000. Effect of sulfur containing amino acids and insulin injection on streptozotocin diabetic rats. J. Drug Res. Egypt, 23: 213-224.
15. Elyazji, N., 2000. Physiological and histological changes associated with the administration of glibenclamide in diabetic rats. Ph.D. Thesis, Faculty of Girls, Ain Shams University, Egypt.
16. Gawronska-Szklarz, B., D.H. Musial, A. Pawlik and B. Paprota, 2003. Effect of experimental diabetes on pharmacokinetic parameters of lidocaine and MEGX in rats. Pol. J. Pharmacol., 55: 619-624.
17. George, M., E. Ayuso, A. Casellas, C. Costa, J.C. Devedjian and F. Bosch, 2002. βcell expression of IGF-I leads to recovery from type 1 diabetes. J. Clin. Invest., 109: 1153-1163.
18. Grover, J.K., S. Yadav and V. Vats, 2002. Medicinal plants of India with anti-diabetic potential. J. Ethnopharmacol., 81: 81-100.
19. Haeba, M.H., A.I. Mohamed, A.W. Mehdi and G.A. Nair, 2002. Toxicity of nerium oleander leaf extract in mice. J. Environ. Biol., 23: 231-237
20. Hebden, R.A., S.M. Gardiner, T. Bennet and I.A. Macdonald, 1989. The influence of streptozotocin-induced diabetes mellitus. Am. J. Physiol., 257: R932-R938.]
21. Hosseinzadeh, H., H.M.H. Khodaparast and H. Shokohizadeh, 1998. Antihyperglycaemic effect of Saliva leriifolia Benth leaf and seed extract in mice. Iran. J. Med. Sci., 23: 78-80.
22. Krauss, H., J. Kozlik, M. Gryzymislawski, P. Sosnowski, K. Mikrut, J. Piatek and J. Paluszak, 2003. The influence of glimepiride on the oxidative state of rats with streptozotocin-induced hyperglycemia. Med. Sci. Monit., 10: BR389-BR393.
23. Mondal, D.K., B.M. Yousuf, L.A. Banu, R. Ferdousi and K.M. Shamim, 2004. Effect of fenugreek seeds on the fasting blood glucose level in the streptozotocin-induced diabetic rats. Mymensingh Med. J., 13: 161-164.
24. Mythili, M.D., R. Vyas, G. Akila and S. Gunasekaran, 2004. Effect of STZ on the ultrastructure of rat pancreatic islets. Microsc. Res. Tech., 63: 274-281.
25. NCCLS, 2001. Protection of Laboratory Workers from Occupationally Acquired Infection: Approved Guideline. 2nd Edn., National Committee For Clinical Laboratory Standards, Wayne, PA., USA.
26. Nieszner, E., I. Posa, E. Kocsis, G. Pogatsa, I. Preda and M.Z. Koltai, 2002. Influence of diabetic state and that of different sulfonylureas on the size of myocardial infraction with and without ischemic preconditioning in rabbits. Exp. Clin. Endocrinol. Diabetes, 110: 212-218.
27. Ravi, K., K. Sivagnanam and S. Subramaniam, 2004. Anti-diabetic activity of Eugenia jambolana seed kernels on streptozotocin-induced diabetic rats. J. Med. Food., 7: 187-191.
28. Sato, J., I. Ohsawa, Y. Oshida, Y. Sato and N. Sakamoto, 1993. Effects of glimepiride on in vivo insulin action in normal and diabetic rats. Diabetes Res. Clin. Pract., 22: 3-9.
29. Seifrer, S. and S. England, 1982. Energy Metabolism. In: The Liver: Biology and Pathology, Arias, I., H. Propper and D. Schacter (Eds.). Rauen Press, New York, USA., pp: 219-249.
30. Setter, S.M., J.L. Iltz, J. Thams and R.K. Campbell, 2003. Metformin hydrochloride in the treatment of type 2 diabetes mellitus: A clinical review with a focus on dual therapy. Clin. Ther., 25: 2991-3025.
31. Szkudelski, T., 2001. The mechanism of alloxan and streptozotocin action in B cells of the rat pancreas. Physiol. Res., 50: 537-546.
32. Tanaka, K., S. Nanbara, T. Tanaka, H. Koide and T. Hayashi, 1998. Aminotransferase activity in the liver of diabetic mice. Diabetes Res. Clin. Pract., 19: 71-75.
33. Thomas, L., 1998. Alanine Aminotransferase (ALT). In: Clinical Laboratory Diagnostics, Thomas, L. (Ed.). 1st Edn. Frankfort: TH-Books Verlagsgesellschaft, USA., pp: 55-56.
34. Travis, J.C., 1980. Clinical Radioimmunoassay. State-of-the-Art. Scientific Newsletters, Anaheim, CA., USA., ISBN: 9780930914066, Pages: 160.
35. Trinder, P., 1969. Glucose GOD-PAP method enzymatic and colorimetric method Ann. Clin. Biochem., 6: 24-27.
36. West, E., O.R. Simon and E.Y. Morrison, 1996. Streptozotocin alters pancreatic β-cell responsiveness to glucose within six hours of injection into rats. West Indian Med. J., 45: 60-62.
37. World Health Organization, 1999. Definition, Diagnosis and Classification of Diabetes Mellitus and its Complications: Report of a WHO Consultation. WHO, Geneva, Switzerland.
38. Yanardag, R., O. Ozsoy-Sacan, H. Orak and Y. Ozgey, 2005. Protective effects of glurenorm (gliquidone) treatment on the liver injury of experimental diabetes. Drug. Chem. Toxicol., 28: 483-497.
39. Yaniv, Z., A. Dafni, J. Friedman and D. Palevitch, 1987. Plants used for the treatment of diabetes in Israel. J. Ethnopharmacol., 19: 145-151.
40. Yassin, M.M. and S.N. Mwafy, 2007. Protective potential of glimepiride and nerium oleander extract on lipid profile, body growth rate and renal function in streptozotocin-induced diabetic rats. Turk. J. Biol., 31: 95-102.
41. Yassin, M.M., A.R.A. Ashour and N.R. Elyazji, 2004. Alterations in body weight, protein profile, non-protein nitrogen constituents and kidney structure in diabetic rats under glibenclamide treatment. J. Islamic Univ. Gaza, 12: P37-P54.